ArticleInternational journal of molecular sciences2026

Identification of ANT2 as a Druggable Target for Endocrine-Resistant ERα-Positive Breast Cancer.

Erika Iguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.